Management of Jaundice in Newborns

Diagnostic Approach

• The American Academy of Pediatrics recommends immediate measurement of total serum bilirubin (TSB) or transcutaneous bilirubin (TcB) in any infant with jaundice appearing in the first 24 hours of life, as this is always pathologic and demands urgent evaluation for hemolytic disease and other serious causes 1, 2
• Obtain TSB and/or TcB immediately on any infant jaundiced within 24 hours of birth, and do not rely on visual assessment, as this leads to dangerous errors, particularly in darkly pigmented infants 1, 2
• Essential laboratory workup includes blood type and direct antibody test (Coombs' test), complete blood count with peripheral smear, direct or conjugated bilirubin, and reticulocyte count and G6PD level to identify hemolytic causes 1, 2, 3

Risk Stratification and Interpretation

• Interpret all bilirubin levels according to the infant's age in hours, not days, and use hour-specific nomograms to determine risk zone and guide management 1, 2, 4
• Jaundice in the first 24 hours places the infant in a high-risk category regardless of absolute bilirubin level, and the possible cause must be actively sought 1, 2
• Isoimmune hemolytic disease (ABO or Rh incompatibility) is the most common serious cause, and other causes include G6PD deficiency, sepsis, and cephalohematoma or significant bruising 1, 2, 4, 3

Treatment and Management

• Use age-specific (hour-specific) and risk-stratified nomograms to determine if phototherapy is indicated, and infants with jaundice in the first 24 hours have lower phototherapy thresholds due to higher risk 4, 3
• Risk factors that lower treatment thresholds include gestational age 35-37 weeks, hemolytic disease, G6PD deficiency, sepsis, acidosis, or albumin <3.0 g/dL 4
• Maximize exposed skin surface area by minimizing diapers, head covers, eye masks, and electrode patches, and expect bilirubin decrease of >2 mg/dL within 4-6 hours if phototherapy is effective 3

Follow-Up and Monitoring

• Timing of repeat TSB or TcB depends on the zone in which initial TSB falls and evolution of hyperbilirubinemia, and for rapidly rising bilirubin or infants with risk factors, recheck within 4-12 hours 1, 2, 3
• Continue monitoring until bilirubin levels are clearly declining and below treatment thresholds 1

Critical Pitfalls to Avoid

• Never discharge an infant with jaundice in the first 24 hours without objective bilirubin measurement and clear follow-up plan 1, 2
• Do not subtract direct bilirubin from total bilirubin when making phototherapy decisions, and do not supplement breastfed infants with water or dextrose water 4, 3
• Recognize that visual estimation is unreliable and always obtain objective measurements 1, 2, 4

Newborn Hyperbilirubinemia Management

Risk Stratification and Management

• The American Academy of Pediatrics recommends obtaining a TSB if TcB shows a rapid rise crossing percentiles on the hour-specific nomogram, even if below phototherapy threshold 5
• The American Academy of Pediatrics suggests that every newborn must have risk assessment for severe hyperbilirubinemia before discharge using either predischarge TSB/TcB plotted on the Bhutani nomogram, clinical risk factor assessment, or both 5
• Infants with predischarge TSB/TcB in the high-risk zone (>95th percentile on Bhutani nomogram) are considered high-risk for severe hyperbilirubinemia 5
• The American Academy of Pediatrics recommends follow-up within 24 hours of discharge for infants with TSB/TcB in the high-intermediate or high-risk zone 5
• The American Academy of Pediatrics suggests using the hour-specific AAP phototherapy nomogram with three risk-stratified curves to determine treatment need 5
• For low-risk infants (≥38 weeks, well, no risk factors), the American Academy of Pediatrics recommends routine follow-up per discharge age if TSB is >5 mg/dL below the phototherapy line 5
• For medium-risk infants (≥38 weeks + risk factors OR 35-37 6/7 weeks, well), the American Academy of Pediatrics recommends using the medium-risk phototherapy curve (lower threshold) 5
• For high-risk infants (35-37 6/7 weeks + risk factors), the American Academy of Pediatrics recommends using the high-risk phototherapy curve (lowest threshold) 5
• The American Academy of Pediatrics recommends simultaneous collection of blood type and direct Coombs test when obtaining TSB for elevated TcB, especially if mother is Rh-negative or blood group O 5
• The American Academy of Pediatrics suggests documenting risk assessment, bilirubin level if obtained, and follow-up plan in discharge summary 5

Bilirubin Screening and Measurement in Newborns

Laboratory Evaluation and Interpretation

• If the total serum bilirubin (TSB) is at or below 5 mg/dL (85 μmol/L), a direct or conjugated bilirubin >1.0 mg/dL is considered abnormal and warrants further investigation, according to the American Academy of Pediatrics 6
• The American Academy of Pediatrics recommends that direct-reacting bilirubin and conjugated bilirubin are commonly used interchangeably in clinical practice, though they are not technically identical—direct bilirubin includes both conjugated bilirubin and delta bilirubin, with a strength of evidence based on published data from 2004 6
• Failing to recognize that G6PD levels can be falsely elevated during active hemolysis—a normal level does not rule out G6PD deficiency in a hemolyzing neonate, and repeat testing at 3 months is necessary if strongly suspected, as suggested by the American Academy of Pediatrics 6

Early‑Onset Neonatal Jaundice: Evidence‑Based Assessment and Management

Diagnostic Confirmation

• In infants who develop jaundice within the first 24 hours, transcutaneous bilirubin (TcB) should be used only as a screening tool; total serum bilirubin (TSB) measurement is required to guide management. 7

Correlation Between TcB and TSB

• TcB values generally approximate TSB within a margin of 2–3 mg/dL, allowing clinicians to anticipate serum levels but still necessitating confirmatory TSB testing. 8

Laboratory Evaluation for Hemolysis

• Assessment for glucose‑6‑phosphate dehydrogenase (G6PD) deficiency is recommended as part of the immediate laboratory workup for early‑onset jaundice. 7

Importance of Bilirubin Rate of Rise

• A bilirubin rise of ≥ 0.3 mg/dL per hour during the first 24 hours is considered rapid and signals possible ongoing hemolysis, warranting closer monitoring. 7

Neonatal Jaundice: Evidence‑Based Assessment and Risk Factors

Physiologic Jaundice Timeline

• In term newborns, physiologic jaundice usually begins after the first 24 hours of life, peaks between days 3–5, and resolves within 1–2 weeks. (American Academy of Pediatrics, Pediatrics 2004) 9

Objective Bilirubin Measurement

• The American Academy of Pediatrics advises that visual inspection alone is unreliable—especially in infants with darker skin pigmentation—and recommends obtaining an objective total serum bilirubin (TSB) or transcutaneous bilirubin (TcB) measurement before making management decisions. (AAP, Pediatrics 2004) 9

G6PD Deficiency as a Risk Factor

• Glucose‑6‑phosphate dehydrogenase (G6PD) deficiency typically produces a late‑onset rise in bilirubin (after day 3–4) and was responsible for approximately 31 % of kernicterus cases in one reported series; clinicians should consider this diagnosis especially in male infants of Mediterranean, Middle Eastern, African, or Asian ancestry. (AAP, Pediatrics 2004) 9